Physician profile
Darrell J Youngman
NPI 1013970441
$1,282.38
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $131 · 2021: $215 · 2022: $277 · 2023: $311 · 2024: $92.98.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $404.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $403.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $296.78 | 2021-2024 | Assurity, Jot Dx, Accent |
| Medtronic Vascular, INC. | $150.00 | 2019 | |
| Novartis Pharmaceuticals Corporation | $146.06 | 2022-2024 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $114.17 | 2019-2024 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $92.29 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $81.41 | 2019-2023 | Xarelto |
| Merck Sharp & Dohme LLC | $71.82 | 2021-2023 | Verquvo |
| E.R. Squibb & Sons, L.L.C. | $66.65 | 2022-2023 | Eliquis |
| Amgen INC. | $62.19 | 2020-2022 | |
| Boston Scientific Corporation | $50.72 | 2021-2023 | Watchman Flx, Watchman Access System |
| Pfizer INC. | $40.78 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $31.88 | 2019 | |
| Medtronic, INC. | $29.32 | 2021-2022 | |
| Amarin Pharma, INC. | $26.27 | 2020-2021 | |
| Alnylam Pharmaceuticals INC. | $22.04 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Darrell Youngman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.